Serina Therapeutics, Inc. Retained Earnings
Serina Therapeutics, Inc. (SER) had Retained Earnings of -$76.75 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$76.75M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$70.40M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$63.50M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$60.16M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$76.75M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$70.40M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$63.50M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$60.16M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$55.58M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | -$49.13M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$44.32M 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$41.58M 10-K · filed 2025-03-24 | -$21.77M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$42.99M 10-K · filed 2025-03-24 | -$23.18M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$48.19M 10-K · filed 2025-03-24 | -$5.43M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$33.18M 10-K · filed 2025-03-24 | -$131.01M 10-K · filed 2024-03-22 |
| 2023-09-30 | -$127.56M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$122.16M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$119.49M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$116.21M 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$113.51M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$111.07M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$108.45M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$105.75M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$103.59M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$101.64M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$99.16M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$97.07M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$94.63M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$92.08M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$89.39M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$86.21M 10-K · filed 2021-03-31 | |
| 2019-09-30 | -$83.50M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$80.28M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$77.19M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$74.05M 10-K/A · filed 2020-03-31 | |
| 2017-12-31 | -$66.55M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |